References
- Shannon BA, Cohen RJ, de Bruto H, et al. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol. 2008;180(4):1257–1261; discussion 1261.
- Maturen KE, Nghiem HV, Caoili EM, et al. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol. 2007;188(2):563–570.
- Professionals S-O. EAU guidelines: renal cell carcinoma. Uroweb n.d.; [cited 2021 Jan 8]. Available from: https://uroweb.org/guideline/renal-cell-carcinoma/.
- NCCN Clinical Practice Guidelines in Oncology n.d.; [cited 2020 Oct 16]. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx.
- Veltri A, Garetto I, Tosetti I, et al. Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses: retrospective analysis on 150 cases. Eur Radiol. 2011;21(2):393–401.
- Richard PO, Lavallée LT, Pouliot F, et al. Is routine renal tumor biopsy associated with lower rates of benign histology following nephrectomy for small renal masses? J Urol. 2018;200(4):731–736.
- Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60(3):578–584.
- Motzer RJ, Barrios CH, Kim TM, et al. Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma. J Clin Oncol. 2014;32(25):2765–2772.
- Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology. 2005;236(2):441–450.
- TNM Classification of Malignant Tumours, 8th Edition | Wiley n.d.; [cited 2022 April 20]. Available from: https://www.wiley.com/en-nl/TNM+Classification+of+Malignant+Tumours%2C+8th+Edition-p-9781119263562.
- Marconi L, Dabestani S, Lam TB, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69(4):660–673.
- Volpe A, Mattar K, Finelli A, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol. 2008;180(6):2333–2337.
- Neuzillet Y, Lechevallier E, Andre M, et al. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004;171(5):1802–1805.
- Nazzani S, Bandini M, Preisser F, et al. Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: a population based analysis. Surg Oncol. 2019;28:201–207.
- Bhindi B, Thompson RH, Lohse CM, et al. The probability of aggressive versus indolent histology based on renal tumor size: implications for surveillance and treatment. Eur Urol. 2018;74(4):489–497.
- Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol. 2010;195(6):W421–427.
- Pedrosa I, Sun MR, Spencer M, et al. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics. 2008;28(4):985–1003.
- Johnson DC, Vukina J, Smith AB, et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol. 2015;193(1):30–35.
- Abel EJ, Heckman JE, Hinshaw L, et al. Multi-quadrant biopsy technique improves diagnostic ability in large heterogeneous renal masses. J Urol. 2015;194(4):886–891.
- Shapiro DD, Abel EJ. Predicting aggressive behavior in small renal tumors prior to treatment. Ann Transl Med. 2018;6:46.
- Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project) – European Urology Focus n.d.; [cited 2021 Jan 12]. Available from: https://www.eu-focus.europeanurology.com/article/S2405-4569(20)30210-8/fulltext.